NHS England refers 10 mental health trusts to CQC over Oxevision consent failures

NHS England has told the Care Quality Commission (CQC) that 10 mental health trusts were not running patient consent for digital monitoring systems, including Oxevision, in line with its digital principles ¹. The referral came to light on 6 October 2026 at the Lampard Inquiry, where NHS England said it had written to the regulator on 2 October and passed its findings to inspection teams ¹.

What the inquiry heard

Oxevision, made by LIO Health, uses infrared sensors and cameras in patients' bedrooms to track breathing and pulse, so staff do not need to go into the room ¹. Gareth Harry, NHS England's National Delivery Director for Mental Health, Learning Disability and Autism, told the inquiry that NHS England had first known of safety concerns linked to the system in 2021, and that those concerns covered consent, patient observations and human rights ¹.

The inquiry was shown a 2022 internal NHS England email in which a staff member said they knew of trusts where patients were "not being given the choice to refuse being filmed" ¹. In 2023 NHS England wrote to mental health trusts telling them not to introduce monitoring technology as a blanket measure, and to decide patient by patient, involving the patient where possible ¹. A later review, prompted by the campaign group Stop Oxevision, found the 10 trusts were "not operating their consent mechanisms in line with the digital principles" ¹.

Lawyers for bereaved families asked why NHS England had taken several years to act ¹. Harry said individual trusts, not NHS England, held day-to-day responsibility for following the guidance ¹. The CQC said it considers all information of concern it receives and can take action where a provider falls short ¹.

What it means for the market

For NHS mental health providers, the referral moves consent for passive monitoring from a guidance question into the inspection process ¹. NHS England has shared its review with CQC inspection teams, and its 2023 letter already set the standard those teams can test against: decisions made for each patient rather than ward-wide use ¹.

For suppliers of remote monitoring and vision-based tools, the episode shows where scrutiny will fall: on how the technology is introduced and explained, not only on what it detects. LIO Health's Laura Cozens told the inquiry in October 2025 that patients needed the technology properly explained, and said it had helped prevent serious incidents such as falls on a dementia ward ¹. Counsel to the inquiry, Teniola Onabanjo, asked NHS England whether keenness to innovate might run ahead of scrutiny of consent and ethics for camera technology ¹.

Baroness Lampard has said she would make interim recommendations on bringing in some technologies if she saw a "risk to patient safety" ¹. Such recommendations could come before her final report if urgent safety concerns are identified ¹.

What remains unknown is which trusts are involved, how many patients were affected and whether the CQC will take action against any of them ¹.

Caveats

The account comes from evidence given at a public inquiry that is still hearing witnesses, and the review findings themselves have not been published ¹. The inquiry is examining the deaths of more than 2,000 people who spent time in Essex mental health units between 2000 and the end of 2023, so its central focus is one county ¹.

The CQC was due to give evidence on 7 October, hearings are expected to run until 15 October with a virtual session on 20 October, and the final report is due in 2028 ¹.